SEARCH

SEARCH BY CITATION

References

  • 1
    Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 1998;31:607617.
  • 2
    Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458482.
  • 3
    Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2008;52:519530.
  • 4
    Boyd LM, Labgston K, Thompson K, et al. Survival in cats with naturally occurring chronic kidney disease (2000–2002). J Vet Intern Med 2008;22:11111117.
  • 5
    Brown SA, Crowell WA, Barsanti JA, et al. Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass. J Am Soc Nephrol 1991;1:11691179.
  • 6
    Finco DR, Brown SA, Crowell WA, et al. Effects of dietary phosphorus and protein in dogs with chronic renal failure. Am J Vet Res 1992;53:22642271.
  • 7
    Bro S, Olgaard K. Effects of excess PTH on nonclassical target organs. Am J Kidney Dis 1997;30:606620.
  • 8
    Slatopolsky E, Caglar S, Pennell JP, et al. On the pathogenesis of hyperparathyroidism in chronic renal insufficiency in the dog. J Clin Invest 1971;50:492499.
  • 9
    Polzin D, Osborne CA, Ross S. Chronic kidney disease. In: EttingerSJ, FeldmanEC, eds. Textbook of Veterinary Internal Medicine, 6th ed. St Louis, MO: Elsevier Saunders; 2005:17561785.
  • 10
    National Kidney Foundation. KDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42 (Suppl 3):S1S201.
  • 11
    Schenck PA, Chew DJ. Determination of calcium fractionation in dogs with chronic renal failure. Am J Vet Res 2003;64: 11811184.
  • 12
    Gerber B, Hässig M, Reusch CE. Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure. Am J Vet Res 2003;64:11611166.
  • 13
    Kogika MM, Lustoza MD, Notomi MK, et al. Serum ionized calcium in dogs with chronic renal failure and metabolic acidosis. Vet Clin Pathol 2006;35:441445.
  • 14
    Cortadellas O, Fernández del Palacio MJ, Talavera J, et al. Serum phosphorus concentrations in dogs with leishmaniosis at different stages of chronic kidney disease. Vet Rec 2009;164:487490.
  • 15
    Elliot J. Staging chronic kidney disease. In: ElliotJ, GrauerF, eds. BSVA Manual of Canine and Feline Nephrology and Urology. Gloucester: British Small Animal Association; 2007:159166.
  • 16
    Ramsey IK, Tebb A, Harris E, et al. Hyperparathyroidism in dogs with hyperadrenocorticism. J Small Anim Pract 2005;46: 531536.
  • 17
    Gear RN, Neiger R, Skelly BJ, et al. Primary hyperparathyroidism in 29 dogs: Diagnosis, treatment, outcome and associated renal failure. J Small Anim Pract 2005;46:1016.
  • 18
    Aguilera-Tejero E, López I, Estepa JC, et al. Mineral metabolism in healthy geriatric dogs. Res Vet Sci 1998;64:191194.
  • 19
    Ham K, Greenfield CL, Barger A, et al. Validation of a rapid parathyroid hormone assay and intraoperative measurement of parathyroid hormone in dogs with benign naturally occurring primary hyperparathyroidism. Vet Surg 2009;38:122132.
  • 20
    Torrance AG, Nachreiner R. Human-parathormone assay for use in dogs: Validation, sample handling studies, and parathyroid function testing. J Vet Intern Med 1989;3:8689.
  • 21
    Feldman EC, Hoar B, Pollard R, et al. Pretreatment clinical and laboratory findings in dogs with primary hyperparathyroidism: 210 cases (1987–2004). J Am Vet Med Assoc 2005;227:756761.
  • 22
    Berry J, Friend EJ, Mellor PJ, et al. Vitamin D metabolites in dogs with unusual calcium metabolism disorders. Proceedings of 12th Workshop on Vitamin D, Maastricht 2003, 80.
  • 23
    Barber PJ, Elliot J. Feline chronic renal failure: Calcium homeostasis in 80 cases diagnosed between 1992 and 1995. J Small Anim Pract 1998;39:108116.
  • 24
    Polzin DJ, Osborne CA, Ross S. Evidence-based management of chronic kidney disease. In: BonaguraJD, TwedtDC, eds. Current Veterinary Therapy XIV. St Louis, MO: Saunders-Elsevier; 2008:872878.
  • 25
    Wilson I, Felsenfeld A, Drezner MK, et al. Altered divalent ion metabolism in early renal failure: Role of 1,25(OH2)D3. Kidney Int 1985;23:565573.
  • 26
    Martinez I, Saracho R, Montenegro J, et al. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 1997;29:496502.
  • 27
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002;39:S1S266.
  • 28
    Schenck PA, Chew DJ. Prediction of serum ionized calcium concentration by use of serum total calcium concentration in dogs. Am J Vet Res 2005;66:13301336.
  • 29
    Lees GE, Brown SA, Elliott J, Grauer GE. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum consensus statement (small animal). J Vet Intern Med 2005;19: 377385.
  • 30
    Costa FA, Goto H, Saldanha LC, et al. Histopathologic patterns of nephropathy in naturally acquired canine visceral leishmaniasis. Vet Pathol 2003;40:677684.
  • 31
    Zatelli A, Borgarelli M, Santilli R, et al. Glomerular lesions in dogs infected with Leishmania organisms. Am J Veter Res 2003;64:558561.
  • 32
    Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular disease in the dog: A review of 137 cases (1985–1992). J Am Anim Hosp Assoc 1996;32:313322.